Open Nav

Rafael Pharmaceuticals

  • Sanjeev Luther, Rafael Pharmaceuticals

Find co-development partners

  • Date:Thursday, October 18
  • Time:10:45 AM - 11:00 AM
  • Room:Elizabethan D
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:To develop innovative, highly selective, well tolerated and highly effective anti-cancer agents by selectively targeting altered metabolism in cancer cells Immediate Objective: Become a Pancreatic Cancer Company -improve the quality of life of patients with Pancreatic Cancer, which is the deadliest cancer worldwide with very limited treatment options Current Vision: Become a Gastrointestinal Cancer Company - enhancing the lives of patients with Gastrointestinal (GI) Cancers
  • Company Website:Rafael Pharma
  • Company HQ City:Cranbury
  • Company HQ Country:United States
  • Company HQ State:New Jersey                 
  • CEO/Top Company Official:Sanjeev Luther
  • Year Founded:2001
  • Main Therapeutic Focus:Oncology
  • Lead Product in Development :CPI 613
  • Development Phase of Primary Product:Phase III
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :3
Sanjeev Luther
Rafael Pharmaceuticals